Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Advances in Therapy|February 6, 2016
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of AdministrationGerolamo Bianchi, Roberto Caporali, Monica Todoerti, et al.
Drugs|January 22, 2013
Glucocorticoids in rheumatoid arthritisRoberto Caporali, Monica Todoerti, Garifallia Sakellariou, et al.
Rheumatology (Oxford, England)|October 6, 2018
Randomized controlled trials and real-world data: differences and similarities to untangle literature dataSara Monti, Vittorio Grosso, Monica Todoerti, et al.
Clinical and Experimental Rheumatology|October 17, 2013
The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic eraRoberto Caporali, Carlo Alberto Scirè, Monica Todoerti, et al.
Clinical and Experimental Rheumatology|September 29, 2017
One year in review 2017: novelties in the treatment of rheumatoid arthritisFrancesco Ferro, Elena Elefante, Nicoletta Luciano, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label useMonica Todoerti, Nicolo' Pipitone, Marco Matucci-Cerinic, et al.
Neuroimmunomodulation|September 18, 2014
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritisRoberto Caporali, Monica Todoerti, Carlo Alberto Scirè, et al.
Arthritis Research & Therapy|May 16, 2012
Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised studyCarlomaurizio Montecucco, Monica Todoerti, Garifallia Sakellariou, et al.
Rheumatology (Oxford, England)|June 30, 2009
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapseCarlo A Scirè, Carlomaurizio Montecucco, Veronica Codullo, et al.
Annals of the New York Academy of Sciences|April 20, 2010
Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritisMonica Todoerti, Carlo Alberto Scirè, Nicola Boffini, et al.
Pageof 3